Cite

HARVARD Citation

    Shibata, A. et al. (2017). Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA. Journal of autoimmunity. pp. 28-38. [Online]. 
  
Back to record